# Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer

> **NCT07219303** · NA · RECRUITING · sponsor: **Fox Chase Cancer Center** · enrollment: 80 (estimated)

## Conditions studied

- Prostate Cancer (Adenocarcinoma)

## Interventions

- **RADIATION:** adaptive stereotactic body radiation therapy (SBRT) with a SIB

## Key facts

- **NCT ID:** NCT07219303
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-25
- **Primary completion:** 2033-08-01
- **Final completion:** 2033-11-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07219303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07219303, "Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07219303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*